TABLE 2.

Drug-susceptibility of major Gram-negative bacteria of LRTI patients from different wards (%).

Antibacterials	Pseudomonas aeruginosa			Acinetobacter baumannii			Klebsiella pneumoniae
	PW (n = 23)	ARD (n = 156)	RICU (n = 975)	PW (n = 12)	ARD (n = 79)	RICU (n = 657)	PW (n = 34)	ARD (n = 84)	RICU (n = 424)
Piperacillin/Tazobactam	89.96	70.51	49.64	41.67	18.99	3.65	79.41	78.57	12.97
Ceftazidime	100.00	73.72	57.44	91.67	17.72	4.87	69.70	72.62	7.31
Cefoperazone/Sulbactam	–	–	–	83.33	31.65	18.41	76.47	67.85	9.67
Cefepime	100.00	71.15	58.94	66.67	26.58	4.11	67.65	77.38	11.79
Imipenem	82.61	57.05	7.28	66.67	13.97	2.73	91.18	83.33	17.69
Meropenem	95.65	60.26	12.41	66.67	17.72	3.35	94.11	83.33	18.40
Amikacin	100.00	87.18	92.92	100.00	21.52	10.20	100	90.48	27.12
Tobramycin	91.30	91.67	92.13	75.00	30.38	22.68	82.35	85.71	18.40
Gentamicin	86.96	82.05	80.10	–	–	–	–	–
Ciprofloxacin	91.30	70.51	48.41	91.67	21.52	5.63	88.24	64.29	8.02
Levofloxacin	91.30	66.26	47.38	91.67	17.72	4.41	97.06	60.71	8.25
Trimethoprim/Sulfamethoxaz	–	–	–	91.67	44.30	19.03	79.41	79.76	20.99
Doxycycline	–	–	–	100.00	35.44	6.24	79.41	52.38	33.02
Minocycline	–	–	–	100.00	62.03	17.66	85.29	57.14	40.09
Tigecycline	–	–	–	100.00	82.28	70.47	100.00	100.00	95.75

PW, pediatric ward; ARD, adult respiratory ward; RICU, respiratory intensive care unit.